Dong-A University Research Foundation for Industry-Academy Cooperation
发明人:
Young Hyun YOO,Hye Young KIM
申请号：
US15336009
公开号：
US20180066250A1
申请日:
2016.10.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A pharmaceutical composition for preventing and treating endocrine disrupting chemicals-induced diseases and a treating method using the same. Since the composition has an effect of decreasing lipid accumulation caused by endocrine disrupting chemicals, for example, persistent organic pollutants (POPs) including polychlorinated biphenyl and the like and can improve insulin resistance caused by the POPs through reduction of insulin receptor substrate 1 (IR1), the composition can be helpfully used for treating diseases including obesity, insulin resistance, and the like caused by the endocrine disrupting chemicals. Further, according to the present disclosure, the composition has an effect of excreting the endocrine disrupting chemicals.
